T. Rowe Price Associates’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,907,436
| Closed | -$114M | – | 2645 |
|
|
2020
Q2 | $114M | Buy |
1,907,436
+100,008
| +6% | +$5.98M | 0.01% | 598 |
|
|
2020
Q1 | $107M | Buy |
1,807,428
+251,656
| +16% | +$14.9M | 0.02% | 555 |
|
|
2019
Q4 | $85.2M | Buy |
1,555,772
+639,994
| +70% | +$35.1M | 0.01% | 714 |
|
|
2019
Q3 | $25.9M | Sell |
915,778
-7,174
| -0.8% | -$203K | ﹤0.01% | 1078 |
|
|
2019
Q2 | $30.6M | Buy |
922,952
+8,970
| +1% | +$298K | ﹤0.01% | 1037 |
|
|
2019
Q1 | $31.1M | Buy |
913,982
+2,010
| +0.2% | +$68.3K | ﹤0.01% | 1032 |
|
|
2018
Q4 | $25M | Buy |
911,972
+44,913
| +5% | +$1.23M | ﹤0.01% | 1076 |
|
|
2018
Q3 | $25.3M | Buy |
+867,059
| New | +$25.3M | ﹤0.01% | 1142 |
|